last update: 11-10-2638

 

 
 

 

 
 

 

 
 
 

Articles

MAHAK deputy managing director, Mr. Mehdi Khajenouri, attended WCLS held on November 18-19, 2013 in Cape Town, South Africa, organized by the Union for International Cancer Control and several partners, and hosted by the Cancer Association of South Africa.The World ...

MAHAK deputy managing director, Mr. Mehdi Khajenouri, attended WCLS held on November 18-19, 2013 in Cape Town, South Africa, organized by the Union for International Cancer Control and several partners, and hosted by the Cancer Association of South Africa.
 
The World Cancer Leaders’ Summit is an important annual high-level policy meeting dedicated exclusively to furthering global cancer control.  The event brings together key decision makers from around the world and encourages timely debate on emerging issues related to cancer.  It provides an important forum to secure a coordinated, multileveled global response to address the spiraling cancer epidemic as one of the four main non-communicable diseases (NCDs) worldwide.  The main objectives of this event under the theme of ‘Closing the Cancer Divide by 2025’ included:
 
 
•    Raising awareness among leading decision makers to ensure cancer is a global health priority
 
•    Providing a forum to exchange information and innovative ideas on how to reverse the cancer epidemic and ensure a sustainable response 
 
•    Defining compelling messages to support the global call to action against cancer
 
•    Creating a force which galvanizes politicians and policy makers and increases cancer’s visibility on the international public health agenda
 
We at MAHAK, would like to take this opportunity to thank all those involved in organizing and attending this paradigm shifting event and are pleased that we had this opportunity to participate in this summit and benefit from this unique possibility to discuss, learn, and support each other and to provide action-oriented solutions for achieving our common goals in the struggle against childhood and adult cancer.